April 23, 2023
1 min read
Save
Neuspera Medical receives FDA clearance of micro-implant neurostimulation therapy system
Key takeaways:
- Neuspera Medical has announced FDA clearance of its Neuspera ultra-miniaturized system.
- The system utilizes a wireless platform and wearable device to provide peripheral nerve stimulation.
Neuspera Medical has announced FDA clearance of its Neuspera ultra-miniaturized neurostimulation therapy system, according to a company press release.
The Neuspera ultra-miniaturized system utilizes a wireless platform and wearable device to provide peripheral nerve stimulation for patients with chronic pain.
“We look forward to bringing this innovative technology to physicians and patients in the U.S.,” Steffen Hovard, CEO of Neuspera Medical, said in the release. “The Neuspera ultra-miniaturized system has the potential to revolutionize the way physicians treat patients battling chronic pain while restoring patients’ health and quality of life,” Hovard added.
Published by:
Read more about